Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...
Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...
Lucinda Charles-Jones, Non-executive Director & Chair or RemCo for Virgin Money and Rank Group (plus a Criticaleye Board Mentor) and Jim Devine, Group HRD, Spirax Group speak to us about some of the findings of our ...
Displaying 1 to 3 of 409
 (002).png "Palo Alto Networks"){kind=logo}
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
